sojyam 24h (paziņots 2008.) tablete
physcience laboratoire - tablete
arthroflex (paziņots 2008.) kapsula
physcience laboratoire - kapsula
iclusig
incyte biosciences distribution b.v. - ponatinibs - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. skatīt nodaļas 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.
pemazyre
incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - antineoplastiski līdzekļi - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
elocom 1 mg/g ziede
organon biosciences s.r.l., romania - mometazona furoāts - ziede - 1 mg/g
elocom 1 mg/g krēms
organon biosciences s.r.l., romania - mometazona furoāts - krēms - 1 mg/g
arcoxia 90 mg apvalkotās tabletes
organon biosciences s.r.l., romania - etorikoksibs - apvalkotā tablete - 90 mg
arcoxia 60 mg apvalkotās tabletes
organon biosciences s.r.l., romania - etorikoksibs - apvalkotā tablete - 60 mg
arcoxia 90 mg apvalkotās tabletes
organon biosciences s.r.l., romania - etorikoksibs - apvalkotā tablete - 90 mg
arcoxia 120 mg apvalkotās tabletes
organon biosciences s.r.l., romania - etorikoksibs - apvalkotā tablete - 120 mg